ScienceDex / Researcher record
Long, Casey
- Dynport Vaccine Company, LLC (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
- Early Career
NIH Funding · FY2023
Award data coverage
One fiscal year is available for this record. This does not establish the first NIH award or current employer.
Single fiscal year on record (FY2023): $1.8M in linked award amounts across 1 award record · Award-linked rank #4461.
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2023 · selected1 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2023 onlyCareer claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Long, Casey as a PI. Multi-PI records show the full award amount for context.
- 75N93022D00016-0-759302300001-1N01Contact PIEARLY PHASE CLINICAL TRIAL UNITS (EPCTU): PHASE I CLINICAL TRIAL TO EVALUATE A SARS-COV-2 THERAPEUTIC$1.8Maward amount
Award organization
Organizations that administered FY2023 awards listing Long, Casey as a PI.
FY2023 award administered by Dynport Vaccine Company, LLC (MD).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2023First NIH AwardDynport Vaccine Company, LLC
- 2023$500K Cumulative Funding
- 2023$1M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #4461
- 2023Entered Top 25% NationallyRanked #4461